Labcorp Holdings Inc. (LH) stock
Close on Nov 11, 2026Market cap $30.23BP/E 30.5Yield 0.77%
Labcorp Holdings Inc. grew revenue 6.0% to $14.59B over the twelve months to Sep 30, 2026. Operating income rose 12.6% to $1.50B, moving the operating margin from 9.7% to 10.3%. Free cash flow was $1.29B, down 6.8% from a year earlier. At the latest close the market valued the company at $30.23B, 30.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $30.23B
- P/E ratio
- 30.5
- Price to sales
- 2.07
- Price to book
- 3.42
- Dividend yield
- 0.77%
- Free cash flow yield
- 4.26%
Fundamentals
- Revenue
- $14.59B
- Net income
- $1.00B
- EPS, diluted
- $12.19
- Free cash flow
- $1.29B
- Book value per share
- $108.43
- Diluted shares
- 82M
Trading
- Next earnings
- Feb 16, 2027 (estimated, before the open)
- Previous close
- $370.88
- Open
- $369.33
- Day's range
- $367.33 – $372.49
- Volume
- 741,770
- Average volume (20 days)
- 795,168
- Index membership
- S&P 500 (since Jun 2024), Russell 1000 (since Jun 2024), Russell 3000 (since May 2024)
- Beta (5 years)
- 0.59
- 52-week range
- $245.00 – $375.10
- RSI (14 days)
- 71.7
- Volatility (1 year)
- 24.1%
- Relative volume
- 0.70×
- WACC
- 7.2%
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | LH | S&P 500 | Difference | LH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.2% | -2.4% | +21.7 pts | ||
| 3 months | +15.7% | -1.2% | +16.8 pts | ||
| Year to date | +49.5% | +12.3% | +37.2 pts | ||
| 1 year | +40.2% | +12.4% | +27.7 pts | ||
| 3 years | +87.6% | +78.8% | +8.8 pts | +23.3% | +21.4% |
| 5 years | +59.3% | +75.2% | −15.9 pts | +9.8% | +11.9% |
| 10 years | +266.1% | +311.1% | −45.0 pts | +13.9% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Labcorp filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Update
- Update
- Update
About Labcorp
Services-Medical Laboratories
Labcorp Holdings Inc. provides comprehensive laboratory diagnostics and drug development services through two primary segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). Through its Dx segment, the company offers routine clinical testing, specialized esoteric assays, genomic analyses, and direct-to-consumer health panels. Its BLS division delivers central laboratory services, preclinical safety assessments, and analytical solutions that support clinical trials and therapeutic development. Labcorp serves a broad range of clients, including physicians, hospitals, health systems, academic researchers, and individual patients, as well as pharmaceutical, biotechnology, and medical device organizations.
Company profile, executives and historyLabcorp stock: common questions
What is Labcorp's stock price?
LH closed at $372.23 on Nov 11, 2026, up 0.36% on the day. Over the past 52 weeks it traded between $245.00 and $375.10.
What is Labcorp's market cap?
Labcorp was worth $30.23B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is LH's P/E ratio?
LH trades at 30.5 times earnings, based on diluted earnings per share of $12.19 over the twelve months to Sep 30, 2026.
How much revenue does Labcorp make?
Labcorp reported revenue of $14.59B for the twelve months to Sep 30, 2026, up 6.0% from a year earlier.
Does Labcorp pay a dividend?
Yes. Labcorp paid $2.88 per share over the last twelve months, a yield of 0.77% at the latest price.
When does Labcorp report earnings next?
Labcorp is expected to report Q4 FY2026 results on Feb 16, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has LH stock performed over the past year?
Including dividends, LH returned +40.2% over the past year, against +12.4% for the S&P 500.
How many LH shares are sold short?
3M shares were sold short at the latest FINRA report, 3.15% of the float, or 3.0 days of average trading volume.
Who are Labcorp's competitors?
Companies most similar to Labcorp by business, industry and size include DGX, FTRE, RDNT, NTRA, GH.
See a number that looks wrong?